Browse Tag


Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home

4 mins read

The FINANCIAL --  Early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home or in other community settings.…

Nestlé successfully completed acquisition of Aimmune Therapeutics

4 mins read

THE FINANCIAL — Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. (Nasdaq: AIMT). Joining Nestlé Health Science (NHSc) as a stand-alone business unit called Aimmune Therapeutics, a Nestlé Health Science company, it will manage NHSc‘s global pharmaceutical business. “Nestlé Health Science’s acquisition of Aimmune Therapeutics marks an important milestone in our…

Children’s asthma attacks reduced and lung function improved by Dupixent in a randomized phase 3 trial

3 mins read

The FINANCIAL — A pivotal Phase 3 trial of Dupixent® (dupilumab) met its primary and all key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate-to-severe asthma. In a broad type 2 inflammatory asthma patient population, defined as having elevated eosinophils (EOS) or elevated fractional exhaled nitric oxide (FeNO), Dupixent added to standard…

Apple Watch could help people with asthma

3 mins read

The FINANCIAL — Apple announced Apple Watch Series 6, introducing a revolutionary Blood Oxygen feature that offers users even more insight into their overall wellness. Apple is joining forces with researchers to conduct three health studies that include using Apple Watch to explore how blood oxygen levels can be used in future health applications. This year,…